Overview
Balance Sheet
Cash Flow
Growth Analysis
2023
2022
2022
2021
2020
Profitability Metrics
Gross Margin
-2.96%
Operating Margin
-146.20%
Net Margin
141.94%
Efficiency Metrics
Revenue per Expense Ratio
0.70
R&D as % of Revenue
0.00%
Earnings Quality
EBITDA Margin
189.77%
Income Tax Rate
0.00%
EPS
0.7700000000
Balance Sheet Analysis
Current Ratio
0.00
Cash Ratio
0.00
Working Capital
$0.00
Debt to Equity
0.59
Debt to Assets
36.58%
Equity Ratio
62.48%
Cash Flow Analysis
Operating Cash Flow Ratio
66.13%
Free Cash Flow Ratio
66.13%
CapEx to Revenue
0.00%
Dividends Paid
$16.74M
Stock Buybacks
$317.58K
Total Shareholder Returns
$17.06M
Cash Position Change
-119.45%
Key Takeaways (2023 FY)
Maintained positive net income growth despite revenue changes
Detailed Growth Metrics
Core Performance
Revenue
137.79%
Net Income
153.38%
EPS
153.47%
Operating Income
-226.23%
Operational Efficiency
R&D Expenses
0.00%
SG&A Expenses
3.32%
Operating Cash Flow
-81.90%
Free Cash Flow
-81.90%
Balance Sheet Health
Assets
-2.28%
Debt
275.49%
Book Value per Share
4.04%
Inventory
0.00%
Shareholder Returns
Dividends per Share
-23.96%
Shares Outstanding
0.00%
Long Term Trends
3Y Revenue/Share
281.67%
5Y Revenue/Share
50.43%
3Y Dividend/Share
-30.70%
5Y Dividend/Share
-36.03%